[ALNY] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 16.09%
YoY- 27.56%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 439,718 750,530 318,754 319,290 335,035 264,306 224,818 56.20%
PBT -137,687 150,741 -274,209 -172,362 -207,021 -405,943 -274,673 -36.81%
Tax 183 2,988 1,815 1,739 472 -23 2,729 -83.41%
NP -137,870 147,753 -276,024 -174,101 -207,493 -405,920 -277,402 -37.17%
Tax Rate - -1.98% - - - - - -
Total Cost 577,588 602,777 594,778 493,391 542,528 670,226 502,220 9.74%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -31.35 19.69 -86.59 -54.53 -61.93 -153.58 -123.39 -59.78%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -1.10 1.18 -2.21 -1.40 -1.68 -3.32 -2.29 -38.58%
EPS Diluted -1.10 1.15 -2.21 -1.40 -1.68 -3.32 -2.29 -38.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.